November 05, 2018 US regulator sails into treacherous opioid waters Public criticism fails to derail approval of Acelrx’s opioid painkiller, but not without a lengthy apologia from Scott Gottlieb.
October 31, 2018 Go or no go? Big decisions for Acelrx, Trevena, Loxo and Astellas Pain drugs look like they could face different outcomes, while targeted cancer agents will have a big month. Two biosimilar decisions also await.
